Clinical Trial Update: Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia. [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and tolerability of repeated doses of an investigational drug in cancer patients with cachexia; study completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cachexia
• Colorectal Cancer
• Non-small Cell Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• Investigational drug (Pfizer-sponsored)

Snippet

Sponsor: Pfizer | Conditions: Cachexia, Non-Small-Cell Lung Cancer | Phase 1 | Status: COMPLETED | Results posted: 2023-12-14